" Role of Diffusion Weighted Image in the Diagnosis and Follow up of Breast Cancer"
1 other identifier
observational
30
0 countries
N/A
Brief Summary
Breast MRI has become an important tool for breast cancer detection and characterization.Contrast enhanced MRI(CE-MRI) is currently the most sensitive detection technique for diagnosis of breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 2, 2024
CompletedFirst Posted
Study publicly available on registry
July 10, 2024
CompletedStudy Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedAugust 7, 2024
August 1, 2024
4 months
July 2, 2024
August 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of correlated false positive results of MRI DWI for the lesion with the positive results by histopathology.
evaluation of the lesion with MRI DWI and histopathology for detect rate of false posive results
6 months
Interventions
Standered breast coils with small field of veiw and thin sections will be used for the examinatio. MRI breast including Axial T1WI, T2WI Stir contrast DWI and Stir sagittal T1WI with contrast traction and subtraction
Eligibility Criteria
Female gender * Age more than 18 years * Patients presented with breast lump * Pateints with recurrent breast cancer following chemotherapy or radiotherapy sessions.
You may qualify if:
- \* Female gender
- Age more than 18 years
- Patients presented with breast lump
- Patients with recurrent breast cancer following chemotherapy or radiotherapy sessions.
You may not qualify if:
- Male gender
- Age younger than 18 years
- Patients with recent breast trauma in the same diseased breast within the last 6 months
- Lactating female presented with acute symptoms as trauma or breast abscess
- Contraindication to perform MRI examination .these include : Cardiac pacemaker -Metallic aneurysm clips
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Related Publications (4)
Stachs A, Stubert J, Reimer T, Hartmann S. Benign Breast Disease in Women. Dtsch Arztebl Int. 2019 Aug 9;116(33-34):565-574. doi: 10.3238/arztebl.2019.0565.
PMID: 31554551BACKGROUNDButti R, Das S, Gunasekaran VP, Yadav AS, Kumar D, Kundu GC. Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges. Mol Cancer. 2018 Feb 19;17(1):34. doi: 10.1186/s12943-018-0797-x.
PMID: 29455658BACKGROUNDShi RY, Yao QY, Wu LM, Xu JR. Breast Lesions: Diagnosis Using Diffusion Weighted Imaging at 1.5T and 3.0T-Systematic Review and Meta-analysis. Clin Breast Cancer. 2018 Jun;18(3):e305-e320. doi: 10.1016/j.clbc.2017.06.011. Epub 2017 Jul 5.
PMID: 28802529BACKGROUNDYilmaz E, Sari O, Yilmaz A, Ucar N, Aslan A, Inan I, Parlakkilic UT. Diffusion-Weighted Imaging for the Discrimination of Benign and Malignant Breast Masses; Utility of ADC and Relative ADC. J Belg Soc Radiol. 2018 Feb 7;102(1):24. doi: 10.5334/jbsr.1258.
PMID: 30039037BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident-radiology department-sohag hospital university
Study Record Dates
First Submitted
July 2, 2024
First Posted
July 10, 2024
Study Start
August 1, 2024
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
August 7, 2024
Record last verified: 2024-08